C-reactive protein as a marker of melanoma progression.

导出 OA

翻译打印收藏纠错

作者： Shenying,Fang ^[1] ; Yuling,Wang ^[1] ; Dawen,Sui ^[1] ; Huey,Liu ^[1] ; Merrick I,Ross ^[1] ; Jeffrey E,Gershenwald ^[1] ; Janice N,Cormier ^[1] ; Richard E,Royal ^[1] ; Anthony,Lucci ^[1] ; Christopher W,Schacherer ^[1] ; Julie M,Gardner ^[1] ; John D,Reveille ^[1] ; Roland L,Bassett ^[1] ; Li-E,Wang ^[1] ; Qingyi,Wei ^[1] ; Christopher I,Amos ^[1] ; Jeffrey E,Lee ^[2]

作者单位： Shenying Fang, Yuling Wang, Dawen Sui, Huey Liu, Merrick I. Ross, Jeffrey E. Gershenwald, Janice N. Cormier, Richard E. Royal, Anthony Lucci, Christopher W. Schacherer, Julie M. Gardner, Roland L. Bassett, Li-E Wang, and Jeffrey E. Lee, University of Texas MD Anderson Cancer Center; John D. Reveille, University of Texas Health Science Center at Houston, Houston, TX; Qingyi Wei, Duke University School of Medicine, Durham, NC; and Christopher I. Amos, Geisel College of Medicine, Dartmouth College, Lebanon, NH. ^[1] Shenying Fang, Yuling Wang, Dawen Sui, Huey Liu, Merrick I. Ross, Jeffrey E. Gershenwald, Janice N. Cormier, Richard E. Royal, Anthony Lucci, Christopher W. Schacherer, Julie M. Gardner, Roland L. Bassett, Li-E Wang, and Jeffrey E. Lee, University of Texas MD Anderson Cancer Center; John D. Reveille, University of Texas Health Science Center at Houston, Houston, TX; Qingyi Wei, Duke University School of Medicine, Durham, NC; and Christopher I. Amos, Geisel College of Medicine, Dartmouth College, Lebanon, NH. jelee@mdanderson.org. ^[2]